Oklo (NYSE:OKLO) Stock Price Down 3.4% After Analyst Downgrade

Oklo Inc. (NYSE:OKLO) shares dropped 3.4% during trading on Thursday after The Goldman Sachs Group lowered their price target on the stock from $91.00 to $65.00. The Goldman Sachs Group currently has a neutral rating on the stock. Oklo traded as low as $53.50 and last traded at $54.80. Approximately 9,377,820 shares traded hands during trading, a decline of 12% from the average daily volume of 10,715,872 shares. The stock had previously closed at $56.70.

A number of other research firms also recently weighed in on OKLO. Texas Capital raised Oklo to a “strong-buy” rating in a research report on Tuesday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $122.00 price target on shares of Oklo in a report on Wednesday. Wedbush reiterated an “outperform” rating on shares of Oklo in a research report on Friday, January 9th. Canaccord Genuity Group decreased their price objective on Oklo from $175.00 to $125.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, HC Wainwright restated a “buy” rating and set a $90.00 price objective on shares of Oklo in a research report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.63.

Insider Activity

In other Oklo news, insider William Carroll Murphy Goodwin sold 2,820 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $56.69, for a total transaction of $159,865.80. Following the completion of the transaction, the insider owned 15,991 shares in the company, valued at $906,529.79. This trade represents a 14.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jacob Dewitte sold 72,960 shares of Oklo stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $60.00, for a total value of $4,377,600.00. Following the sale, the chief executive officer directly owned 751,533 shares in the company, valued at $45,091,980. The trade was a 8.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 2,062,424 shares of company stock worth $169,888,312. Corporate insiders own 18.90% of the company’s stock.

Key Headlines Impacting Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Regulatory and DOE approvals materially de-risk commercialization plans — Oklo’s Atomic Alchemy unit secured an NRC materials license and the DOE approved a Nuclear Safety Design Agreement for its Groves Isotopes Test Reactor, opening an early isotope revenue pathway. Atomic Alchemy DOE approval
• Positive Sentiment: DOE partnership and pilot-project momentum — Oklo signed a deal to build a reactor at Idaho National Lab and has NSDAs under the Reactor Pilot Program, moving the company from concept toward execution and potential early cash from isotopes. DOE Idaho National Lab deal
• Positive Sentiment: Analyst buy-side conviction and institutional accumulation support upside — Several firms reaffirmed coverage or maintained Buy/Overweight ratings and MarketBeat highlights rising institutional ownership and a bullish technical setup that could compress float and amplify rallies. MarketBeat analysis
• Neutral Sentiment: Analyst forecasts point to long runway — HC Wainwright reiterates a Buy and models near-term losses (Q1/Q2 2026 EPS estimates negative) but projects profitability by 2030, signaling industry optimism tempered by multi-year execution risk. (HC Wainwright research)
• Neutral Sentiment: Mixed broker targets — Several broker reports raised or reaffirmed targets even as others trimmed theirs, leaving consensus upside but wider dispersion in near-term expectations. Example coverage roundup: Broker target roundup
• Negative Sentiment: Q4 earnings miss and widening loss pressured the stock — Oklo reported Q4 EPS of ($0.27) vs. consensus ($0.17), prompting short-term selling as the company remains pre-revenue and capital-intensive. Earnings and regulatory update
• Negative Sentiment: Analyst target cuts and headline volatility — Several firms trimmed price targets (Goldman, Citi and others), increasing near-term uncertainty and headline-driven trading. Coverage of the repricing and market reaction: Analyst cuts and market reaction
• Negative Sentiment: Insider selling heightened concern — Recent filings show the CFO sold shares worth several million dollars, which amplifies short-term downward pressure and investor caution. Insider sale report

Hedge Funds Weigh In On Oklo

Hedge funds and other institutional investors have recently modified their holdings of the stock. NBC Securities Inc. grew its position in Oklo by 75.0% in the fourth quarter. NBC Securities Inc. now owns 350 shares of the company’s stock valued at $25,000 after acquiring an additional 150 shares during the period. GAMMA Investing LLC raised its stake in Oklo by 356.3% during the fourth quarter. GAMMA Investing LLC now owns 365 shares of the company’s stock worth $26,000 after acquiring an additional 285 shares in the last quarter. Armstrong Advisory Group Inc. bought a new position in shares of Oklo during the third quarter valued at $27,000. Elevation Point Wealth Partners LLC bought a new position in shares of Oklo during the second quarter valued at $28,000. Finally, Gables Capital Management Inc. bought a new position in shares of Oklo during the third quarter valued at $28,000. Institutional investors own 85.03% of the company’s stock.

Oklo Stock Performance

The company’s 50 day moving average price is $73.41 and its 200 day moving average price is $94.73. The company has a market cap of $9.51 billion, a price-to-earnings ratio of -76.11 and a beta of 0.80.

Oklo (NYSE:OKLO) last announced its earnings results on Tuesday, March 17th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.10). During the same period last year, the business posted ($0.74) EPS. As a group, analysts predict that Oklo Inc. will post -8.2 EPS for the current year.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.